AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33244081 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial and bodily movements available
Number of subjects: 140
Study 33244081 — intervention group
Group type: COMPARATOR
Intervention: Only facial movements available
Number of subjects: 140
Study 33244081 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodily movements available
Number of subjects: 140
Study 33244081 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classifiers for nonverbal cues
Number of subjects: 140
Study 35640310 — intervention group
Group type: EXPERIMENTAL
Intervention: CALM (computer-facilitated CBT intervention)
Number of subjects: 961
Study 35640310 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 961
Study 32318057 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoglobulin (THG)
Number of subjects: 27
Study 32318057 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoglobulin (THG) in high-risk patients
Number of subjects: 27
Study 32318057 — intervention group
Group type: COMPARATOR
Intervention: ATG-Fresenius (ATG-F)
Number of subjects: 27
Study 32687434 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Body Mind Spirit (I‐BMS) intervention
Number of subjects: 100
Study 32687434 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study 34104419 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 0
Study 34104419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32227108 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy clinicians' involvement in research
Number of subjects: 10
Study 32227108 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from a mentor, supervisor, and/or administrator
Number of subjects: 10
Study 32227108 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking out available resources
Number of subjects: 10
Study 32227108 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowing roles and responsibilities
Number of subjects: 10
Study 33966955 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic findings plus education about additional genomic findings and the option to request them (DF + EAF)
Number of subjects: 335
Study 33966955 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic findings only (DF)
Number of subjects: 335
Study 35978377 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) intervention for 72 weeks
Number of subjects: 216
Study 35978377 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 216
Study 32093652 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen Fumarate (KF) 2 mg or 5 mg
Number of subjects: 0
Study 32093652 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 0
Study 35442497 — intervention group
Group type: EXPERIMENTAL
Intervention: Essence of chicken (EOC)
Number of subjects: 34
Study 35442497 — intervention group
Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 34
Study 33798312 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Heixiaoyao powder
Number of subjects: 180
Study 33798312 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 180
Study 33798312 — intervention group
Group type: COMPARATOR
Intervention: Heixiaoyao powder
Number of subjects: 180
Study 35569833 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32441408 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training in normobaric hypoxia (HYP; 15.0% inspired O2)
Number of subjects: 8
Study 32441408 — intervention group
Group type: COMPARATOR
Intervention: High-intensity training in normoxia (NOR; 20.9% inspired O2)
Number of subjects: 8
Study 34312798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg/day
Number of subjects: 72
Study 34312798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide fumarate (TAF) 25 mg/day
Number of subjects: 72
Study 34312798 — intervention group
Group type: COMPARATOR
Intervention: Both TAF and TDF
Number of subjects: 72
Study 32816829 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation (starting within 2 weeks after an exacerbation)
Number of subjects: 70
Study 32816829 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (same programme starting 2 months later)
Number of subjects: 70
Study 32855275 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-AML
Number of subjects: 413
Study 32855275 — intervention group
Group type: COMPARATOR
Intervention: sAML
Number of subjects: 413
Study 32855275 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic transplant in first complete remission
Number of subjects: 413
Study 32149451 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium zirconium cyclosilicate (SZC) 10 g
Number of subjects: 70
Study 32149451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35998955 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat beta-glucan-enriched bread
Number of subjects: 250
Study 35998955 — intervention group
Group type: COMPARATOR
Intervention: Whole-grain wheat bread
Number of subjects: 250
Study 34750392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant gefitinib
Number of subjects: 171
Study 34750392 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 171
Study 34750392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant gefitinib or chemotherapy based on genomic profiling
Number of subjects: 171
Study 33774886 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarettes
Number of subjects: 607
Study 33774886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine e-cigarettes
Number of subjects: 607
Study 32675536 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutures
Number of subjects: 126
Study 32675536 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 126
Study 32675536 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonabsorbable mesh
Number of subjects: 126
Study 32675536 — intervention group
Group type: COMPARATOR
Intervention: Sutures and Nonabsorbable mesh
Number of subjects: 126
Study 37245533 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (20 IU, twice/day) with dulaglutide (1.5 mg/week)
Number of subjects: 80
Study 37245533 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo with dulaglutide (1.5 mg/week)
Number of subjects: 80
Study 37245533 — intervention group
Group type: COMPARATOR
Intervention: Intranasal insulin (20 IU, twice/day) with placebo
Number of subjects: 80
Study 37245533 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo with placebo
Number of subjects: 80
Study 34302899 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental qualities (general parenting styles, parent feeding practices, and parental BMI)
Number of subjects: 50
Study 34302899 — intervention group
Group type: EXPERIMENTAL
Intervention: Structure in general parenting
Number of subjects: 50
Study 34302899 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practice
Number of subjects: 50
Study 34302899 — intervention group
Group type: EXPERIMENTAL
Intervention: Coercive control general parenting
Number of subjects: 50
Study 32943059 — intervention group
Group type: EXPERIMENTAL
Intervention: Colon capsule endoscopy (CCE)
Number of subjects: 349
Study 32943059 — intervention group
Group type: COMPARATOR
Intervention: CT colonography (CTC)
Number of subjects: 349
Study 33188428 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased IL-17 levels (genetically predicted)
Number of subjects: 900
Study 33188428 — intervention group
Group type: EXPERIMENTAL
Intervention: C allele of rs117556572
Number of subjects: 900
Study 33188428 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-α, IL-12p70, decreased IL-17 levels
Number of subjects: 900
Study 33581015 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy (MT) group
Number of subjects: 60
Study 33581015 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy (IT) group
Number of subjects: 60
Study 32669140 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein group (≥2·2 g/kg per d) receiving combined enteral and parenteral nutrition (EN+PN)
Number of subjects: 0
Study 32669140 — intervention group
Group type: COMPARATOR
Intervention: Low protein group (≤1·2 g/kg per d) receiving enteral nutrition (EN) alone
Number of subjects: 0
Study 35233478 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 egg/d for 6 months
Number of subjects: 660
Study 35233478 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control
Number of subjects: 660
Study 32174340 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushing an industrial trolley at different speed values and load conditions
Number of subjects: 96
Study 34923339 — intervention group
Group type: EXPERIMENTAL
Intervention: Mori ramulus (MR) extract
Number of subjects: 36
Study 34923339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33231873 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus best supportive care (BSC)
Number of subjects: 398
Study 33231873 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus best supportive care (BSC)
Number of subjects: 398
Study 33935686 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 128
Study 33935686 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 128
Study 33935686 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIIT and MCT
Number of subjects: 128
Study 32651307 — intervention group
Group type: EXPERIMENTAL
Intervention: IPostC
Number of subjects: 60
Study 32651307 — intervention group
Group type: COMPARATOR
Intervention: IPostC+GA
Number of subjects: 60
Study 33392802 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF) applied locally at the surgical site after necrotic bone removal.
Number of subjects: 28
Study 33392802 — intervention group
Group type: COMPARATOR
Intervention: Control group received traditional surgical therapy with primary closure of the surgical area.
Number of subjects: 28
Study 33032612 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) as first lung image
Number of subjects: 0
Study 33032612 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray (CXR) as first pulmonary image
Number of subjects: 0
Study 33032612 — intervention group
Group type: EXPERIMENTAL
Intervention: LUS or CXR not suggestive of BN and PCT > 1 ng/mL
Number of subjects: 0
Study 33032612 — intervention group
Group type: EXPERIMENTAL
Intervention: LUS or CXR not suggestive of BN and PCT < 1 ng/mL
Number of subjects: 0
Study 35401783 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch combined with intelligent interactive nursing mode of voice, music, and rhythm
Number of subjects: 140
Study 35401783 — intervention group
Group type: COMPARATOR
Intervention: Touch nursing
Number of subjects: 140
Study 33624417 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 39
Study 33624417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32456877 — intervention group
Group type: EXPERIMENTAL
Intervention: SSPNJH (Niño Jesús Hospital procedural sedation-analgesia scale)
Number of subjects: 65
Study 32456877 — intervention group
Group type: EXPERIMENTAL
Intervention: SSPNJH
Number of subjects: 65
Study 35254932 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer comparison feedback
Number of subjects: 263
Study 35254932 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of peer comparison and individual audit feedback
Number of subjects: 263
Study 35254932 — intervention group
Group type: COMPARATOR
Intervention: Individual audit feedback
Number of subjects: 263
Study 35254932 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 263
Study 32084347 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 80
Study 32084347 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 80
Study 33554701 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual scenario simulation combined with problem-based learning (PBL)
Number of subjects: 300
Study 33554701 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching methods
Number of subjects: 300
Study 33267837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonazepam (0.05 mg/Kg)
Number of subjects: 30
Study 33267837 — intervention group
Group type: COMPARATOR
Intervention: Oral lorazepam (0.05 mg/Kg)
Number of subjects: 30
Study 36215079 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter PFO closure plus antithrombotic therapy
Number of subjects: 3740
Study 36215079 — intervention group
Group type: COMPARATOR
Intervention: Antithrombotic therapy alone
Number of subjects: 3740
Study 32869214 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 62
Study 32869214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 35081482 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intolerance of Uncertainty (LIU) manipulation
Number of subjects: 106
Study 35081482 — intervention group
Group type: COMPARATOR
Intervention: High Intolerance of Uncertainty (HIU) manipulation
Number of subjects: 106
Study 34877622 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (1-Hz, 110% RMT, 5 × 60 s trains)
Number of subjects: 54
Study 34877622 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 54
Study 34877622 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 54
Study 34877622 — intervention group
Group type: COMPARATOR
Intervention: Active rTMS and Sham rTMS
Number of subjects: 54
Study 34197791 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivifrail tailored, multicomponent exercise program (24 weeks)
Number of subjects: 24
Study 34197791 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivifrail tailored, multicomponent exercise program (4 weeks)
Number of subjects: 24
Study 34197791 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining after 24 weeks of training
Number of subjects: 24
Study 34197791 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivifrail training
Number of subjects: 24
Study 32473534 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-assisted intervention (AAI)
Number of subjects: 5
Study 32473534 — intervention group
Group type: COMPARATOR
Intervention: Non-animal-assisted intervention (non-AAI)
Number of subjects: 5
Study 35141030 — intervention group
Group type: EXPERIMENTAL
Intervention: Video education (N = 120)
Number of subjects: 240
Study 35141030 — intervention group
Group type: COMPARATOR
Intervention: No video education (N = 120)
Number of subjects: 240
Study 34519832 — intervention group
Group type: EXPERIMENTAL
Intervention: risedronate + CaD
Number of subjects: 276
Study 34519832 — intervention group
Group type: EXPERIMENTAL
Intervention: bone-loading exercises + CaD
Number of subjects: 276
Study 34519832 — intervention group
Group type: COMPARATOR
Intervention: calcium and vitamin D supplements (CaD)
Number of subjects: 276
Study 33745203 — intervention group
Group type: EXPERIMENTAL
Intervention: Football with diet
Number of subjects: 40
Study 33745203 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 33745203 — intervention group
Group type: EXPERIMENTAL
Intervention: Football-only
Number of subjects: 40
Study 33745203 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-only
Number of subjects: 40
Study 33162978 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD‐alum injection (4 μg) into lymph nodes + oral Vitamin D (2000 U/d)
Number of subjects: 12
Study 35531985 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood IPV exposure (i.e., threat)
Number of subjects: 249
Study 34057153 — intervention group
Group type: EXPERIMENTAL
Intervention: Drowning scenario
Number of subjects: 20
Study 34057153 — intervention group
Group type: COMPARATOR
Intervention: Burial scenario
Number of subjects: 20
Study 34570008 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based program
Number of subjects: 115
Study 32828678 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin alone (70 mg/kg) for five days
Number of subjects: 129
Study 32828678 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (70 mg/kg) plus clarithromycin (15 mg/kg) for the initial three days
Number of subjects: 129
Study 34358811 — intervention group
Group type: EXPERIMENTAL
Intervention: One-view mediolateral (MLO) DM-DBT
Number of subjects: 138
Study 34358811 — intervention group
Group type: EXPERIMENTAL
Intervention: One-view craniocaudal (CC) DM-DBT
Number of subjects: 138
Study 34358811 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-view DM-DBT
Number of subjects: 138
Study 34358811 — intervention group
Group type: COMPARATOR
Intervention: CC DM-DBT view
Number of subjects: 138
Study 34358811 — intervention group
Group type: COMPARATOR
Intervention: MLO DM-DBT view
Number of subjects: 138
Study 33022713 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D (1000 IU/d)
Number of subjects: 2259
Study 33022713 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1200 mg/d)
Number of subjects: 2259
Study 33022713 — intervention group
Group type: COMPARATOR
Intervention: Both vitamin D and calcium
Number of subjects: 2259
Study 34841554 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (GoShare bundles) provided preoperatively, at one week post-discharge, and 30 days after surgery.
Number of subjects: 0
Study 34841554 — intervention group
Group type: COMPARATOR
Intervention: Usual care (in-patient discharge education and local paper-based written discharge materials).
Number of subjects: 0
Study 34841554 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (GoShare bundles).
Number of subjects: 0
Study 33009445 — intervention group
Group type: EXPERIMENTAL
Intervention: Toe pulse arrival time (PAT) via PPG foot
Number of subjects: 32
Study 33009445 — intervention group
Group type: COMPARATOR
Intervention: Other conventional pulse transit times (cPTTs) including finger PAT
Number of subjects: 32
Study 36189594 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal time of day (morning)
Number of subjects: 106
Study 36189594 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-optimal time of day (evening)
Number of subjects: 106
Study 36189594 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 106
Study 32324509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose; stored at 4°C
Number of subjects: 0
Study 32324509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-free chocolate; stored at 4°C
Number of subjects: 0
Study 32324509 — intervention group
Group type: COMPARATOR
Intervention: Control chocolate (not specified); stored at 20°C
Number of subjects: 0
Study 35078875 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Decision Support Tool (VDST)
Number of subjects: 113
Study 35078875 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 113
Study 33515998 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase supplementation (1 000 U/kg diet) with 1.0, 1.5, or 2.0 g/kg NPP
Number of subjects: 48
Study 33515998 — intervention group
Group type: COMPARATOR
Intervention: Control group (phytase-absent) with 2.0, 2.5, or 3.0 g/kg NPP
Number of subjects: 48
Study 33515998 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase supplementation
Number of subjects: 48
Study 32510734 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1.2-g dose of oral azithromycin
Number of subjects: 0
Study 32510734 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial adult dose of 500 mg followed by 250 mg per day for 4 days (total cumulative dose of 1.5 g)
Number of subjects: 0
Study 32510734 — intervention group
Group type: EXPERIMENTAL
Intervention: For children aged 5 to 18 years, 10 mg/kg on the first day followed by 5 mg/kg for 4 days
Number of subjects: 0
Study 35397826 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session treatment
Number of subjects: 53
Study 35397826 — intervention group
Group type: COMPARATOR
Intervention: Weekly treatment
Number of subjects: 53
Study 34393215 — intervention group
Group type: EXPERIMENTAL
Intervention: PEM block education session
Number of subjects: 45
Study 32887411 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training program (CTP) of strength exercises and cognitive–motor tasks for 24 weeks, 3 sessions per week
Number of subjects: 31
Study 33794708 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-axis ultrasound guided technique
Number of subjects: 283
Study 33794708 — intervention group
Group type: COMPARATOR
Intervention: Long-axis ultrasound guided technique
Number of subjects: 283
Study 33826205 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-befriending intervention (part of the SUPERB trial)
Number of subjects: 20
Study 34117375 — intervention group
Group type: COMPARATOR
Intervention: Pomegranate juice (PJ)
Number of subjects: 100
Study 34117375 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct supplementation with Urolithin A (500 mg)
Number of subjects: 100
Study 33822361 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 vaccine
Number of subjects: 432
Study 32673736 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 3 facilities (highest percentage of Black residents)
Number of subjects: 4567
Study 32673736 — intervention group
Group type: COMPARATOR
Intervention: Tertile 1 facilities (lowest percentage of Black residents)
Number of subjects: 4567
Study 36149331 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bi-07 (2 × 10^12 CFU)
Number of subjects: 0
Study 36149331 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase (4662 FCC)
Number of subjects: 0
Study 36149331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33428638 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0
Study 33428638 — intervention group
Group type: COMPARATOR
Intervention: Control healthy living course
Number of subjects: 0
Study 32942424 — intervention group
Group type: EXPERIMENTAL
Intervention: Pore-by-pore modeling with optimized contact angle adjustments
Number of subjects: 0
Study 32942424 — intervention group
Group type: COMPARATOR
Intervention: Randomly assigned distributions of contact angle
Number of subjects: 0